Login / Signup

Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock.

Soo Jin NaJeong Hoon YangRyoung-Eun KoChi Ryang ChungYang Hyun ChoKi Hong ChoiDarae KimTaek Kyu ParkJoo Myung LeeYoung Bin SongJin-Oh ChoiJoo-Yong HahnSeung-Hyuk ChoiHyeon-Cheol Gwon
Published in: PloS one (2022)
The use of norepinephrine as a first-line vasopressor was not associated with reductions of in-hospital mortality or arrythmia but could reduce use of additional vasopressors in CS patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors